1-1 of 1
Dee Wynnem, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Results from a Phase 1/2 Study of Lumiliximab (Anti-CD23) in Combination with FCR for Patients with Relapsed CLL with Published FCR Results.

John C. Byrd, MD, Januario Castro, MD, Susan O’Brien, MD, Ian W. Flinn, MD, Andres Forero-Torres, MD, Thomas J. Kipps, MD, PhD, Nyla A. Heerema, PhD, Thomas Lin, MD, Thian Kheoh, PhD, Dee Wynnem, RN, Arturo Molina, MD, MS
Journal: Blood
Blood (2006) 108 (11): 32.
https://doi.org/10.1182/blood.V108.11.32.32
Published: 2006